two significant new approaches for treating and preventing breast cancer

The FDA is close to approving two significant new approaches for treating and preventing breast cancer.

Herceptin (trastuzumab) will be a major breakthrough...it's the first monoclonal antibody for treating metastatic breast cancer.

It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumors that produce excessive amounts of HER2.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote